Jerry Nash
Houston, TXNPI 1801842646
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,137 and has fallen 94.1% since, to $67 in 2023.
Across 77 payments — averaging $22.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$261
- Novartis$172
- Sanofi$134
- EMD Serono, Inc.$133
- Mallinckrodt Enterprises LLC$132
- UCB, Inc.$126
- plus $775 from 18 others
What the payments were for
- Food & beverage$1,732100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 5 | $261 |
| Novartis | 13 | $172 |
| Sanofi | 7 | $134 |
| EMD Serono, Inc. | 3 | $133 |
| Mallinckrodt Enterprises LLC | 11 | $132 |
| UCB, Inc. | 5 | $126 |
| Supernus Pharmaceuticals, Inc. | 6 | $119 |
| Medtronic | 1 | $111 |
| Biohaven Pharmaceuticals, Inc. | 1 | $98 |
| MDD US Operations, LLC | 5 | $96 |
| AbbVie(2 entities) | 4 | $67 |
| Lilly USA, LLC | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Mallinckrodt Hospital Products Inc. | 2 | $24 |
| Abbott | 1 | $23 |
| SK Life Science, Inc. | 1 | $22 |
| Bausch Health US, LLC | 1 | $22 |
| Saol Therapeutics Inc. | 1 | $21 |
| Eisai Inc. | 1 | $20 |
| Acadia Pharmaceuticals Inc | 1 | $19 |
| Adamas Pharmaceuticals, Inc. | 1 | $18 |
| Akcea Therapeutics, Inc. | 1 | $17 |
| Tanabe Pharma America, Inc. | 1 | $17 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.